184 related articles for article (PubMed ID: 32337773)
21. Antibody-mediated rejection with and without donor-specific anti-human leucocyte antigen antibodies: performance of the peripheral blood 8-gene expression assay.
Van Loon E; Lerut E; de Loor H; Kuypers D; Emonds MP; Anglicheau D; Gwinner W; Essig M; Marquet P; Naesens M
Nephrol Dial Transplant; 2020 Aug; 35(8):1328-1337. PubMed ID: 32594133
[TBL] [Abstract][Full Text] [Related]
22. On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes.
Meneghini M; Perona A; Crespo E; Bemelman F; Reinke P; Viklicky O; Giral M; Palou E; Torija A; Donadeu L; Melilli E; Zuñiga J; Sefrin A; Lachmann N; Hu L; Hruba P; Guillot-Gueguen C; Brouard S; Grinyo J; Bestard O
Front Immunol; 2022; 13():924825. PubMed ID: 36248818
[TBL] [Abstract][Full Text] [Related]
23. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
25. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
[TBL] [Abstract][Full Text] [Related]
26. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
[TBL] [Abstract][Full Text] [Related]
27. The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation.
Senev A; Ray B; Lerut E; Hariharan J; Heylen C; Kuypers D; Sprangers B; Emonds MP; Naesens M
Front Immunol; 2022; 13():809059. PubMed ID: 35250981
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
29. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
30. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
[TBL] [Abstract][Full Text] [Related]
31. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
[TBL] [Abstract][Full Text] [Related]
32. Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts.
Everly MJ; Roberts M; Townsend R; Bray RA; Gebel HM
Am J Transplant; 2018 Sep; 18(9):2305-2313. PubMed ID: 29767445
[TBL] [Abstract][Full Text] [Related]
33. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
Süsal C; Wettstein D; Döhler B; Morath C; Ruhenstroth A; Scherer S; Tran TH; Gombos P; Schemmer P; Wagner E; Fehr T; Živčić-Ćosić S; Balen S; Weimer R; Slavcev A; Bösmüller C; Norman DJ; Zeier M; Opelz G;
Transplantation; 2015 Sep; 99(9):1976-80. PubMed ID: 25769065
[TBL] [Abstract][Full Text] [Related]
34. Kidney paired donation in the presence of donor-specific antibodies.
Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
36. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Hum Immunol; 2017 Sep; 78(9):526-533. PubMed ID: 28732720
[TBL] [Abstract][Full Text] [Related]
37. Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes.
Redondo-Pachón D; Pérez-Sáez MJ; Mir M; Gimeno J; Llinás L; García C; Hernández JJ; Yélamos J; Pascual J; Crespo M
Hum Immunol; 2018 Jun; 79(6):424-431. PubMed ID: 29524568
[TBL] [Abstract][Full Text] [Related]
38. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
Heidt S; Haasnoot GW; Witvliet MD; van der Linden-van Oevelen MJH; Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Otten HG; Roelen DL; Claas FHJ
Am J Transplant; 2019 Oct; 19(10):2926-2933. PubMed ID: 31155833
[TBL] [Abstract][Full Text] [Related]
39. Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss.
Nocera A; Tagliamacco A; Cioni M; Innocente A; Fontana I; Barbano G; Carrea A; Ramondetta M; Sementa A; Basso S; Quartuccio G; Klersy C; Bertocchi M; Verrina E; Garibotto G; Ghiggeri GM; Cardillo M; Comoli P; Ginevri F
Am J Transplant; 2017 Mar; 17(3):692-702. PubMed ID: 27501275
[TBL] [Abstract][Full Text] [Related]
40. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]